tiprankstipranks
Trending News
More News >
Mineralys Therapeutics, Inc. (MLYS)
NASDAQ:MLYS
US Market

Compare Mineralys Therapeutics, Inc. (MLYS) vs. Competitors

Compare
582 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Mineralys Therapeutics, Inc.
$33.13
$2.62B
-11.20
195.80%
6 Buy
0 Hold
0 Sell
Strong Buy
Viking Therapeutics
$31.65
$3.58B
-14.94
-22.04%
12 Buy
0 Hold
0 Sell
Strong Buy
Xenon
$41.22
$3.19B
-10.61
4.22%
13 Buy
0 Hold
0 Sell
Strong Buy
Apellis Pharmaceuticals
$26.26
$3.32B
88.45
-20.42%
9 Buy
5 Hold
0 Sell
Moderate Buy
NewAmsterdam Pharma Company
$35.80
$4.06B
-17.53
40.12%
9 Buy
1 Hold
0 Sell
Strong Buy
Centessa Pharmaceuticals
$22.05
$2.96B
-12.11
36.96%
13 Buy
0 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
MLYS
Mineralys Therapeutics, Inc.
33.13
23.77
253.95%
VKTX
Viking Therapeutics
31.65
-7.23
-18.60%
XENE
Xenon
41.22
2.97
7.76%
APLS
Apellis Pharmaceuticals
26.26
-2.33
-8.15%
NAMS
NewAmsterdam Pharma Company
35.80
11.22
45.65%
CNTA
Centessa Pharmaceuticals
22.05
6.79
44.50%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts